0001562180-18-001253.txt : 20180226 0001562180-18-001253.hdr.sgml : 20180226 20180226191610 ACCESSION NUMBER: 0001562180-18-001253 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180220 FILED AS OF DATE: 20180226 DATE AS OF CHANGE: 20180226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Matis Louis CENTRAL INDEX KEY: 0001650991 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37471 FILM NUMBER: 18642385 MAIL ADDRESS: STREET 1: LISE-MEITNER-STRASSE 30 STREET 2: C/O PIERIS PHARMACEUTICALS, INC. CITY: FREISING-WEIHENSTEPHAN STATE: 2M ZIP: 85354 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001583648 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 300784346 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 255 STATE STREET STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-246-8998 MAIL ADDRESS: STREET 1: 255 STATE STREET STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Marika Inc. DATE OF NAME CHANGE: 20130805 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-02-20 false 0001583648 PIERIS PHARMACEUTICALS, INC. PIRS 0001650991 Matis Louis C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109 false true false false Chief Development Officer Stock Options (Right to buy) 8.56 2018-02-20 4 A false 100000.00 0.00 A 2028-02-20 Common Stock 100000.00 100000.00 D The option vests as to 25% of the option shares on January 1, 2019 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter. /s/ Marc D. Mantell, Attorney-in-fact 2018-02-26